After over 2,000 deaths during clinical drug trials in last five years, the government plans to regulate the $500 million sector. Reports say changed drug laws are on the anvil... to make lapses by pharma MNCs a punishable offence and enhance compensation among other steps.
Sources say rules meant to monitor clinical trials under the Drugs and Cosmetics Act would be notified within this month.
After notifying these rules, which will lay down guidelines for pharma companies engaging in drug trials in India, the government will further amend the Drugs and Cosmetics Act to make lapses by pharma MNCs a punishable offence under law
